Free. Unsubscribe any time.
Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. filed 21 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 183 transactions and 537,606 shares. None carries the SEC's AFF10B5ONE flag; all 21 name a plan in a footnote. 6 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-04, came on the same day as the one before it (2026-09-04) and reports 13 transactions against 13 in the filing before it.
- The sales it reports total 25,000 shares, the same as the 25,000 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 21 filings on file run from 2025-02-28 to 2026-09-04, and state 6 plan adoption dates, from 2024-06-13 to 2026-02-23.
Trades in Krystal Biotech, Inc. 183
- ROMANO KATHRYN — 2025-02-27 · S · 750 shares
- Krishnan Krish S — 2025-03-13 · S · 1,100 shares
- Krishnan Krish S — 2025-03-13 · S · 4,944 shares
- Krishnan Krish S — 2025-03-13 · S · 10,931 shares
- Krishnan Krish S — 2025-03-13 · S · 6,769 shares
- Krishnan Krish S — 2025-03-13 · S · 1,256 shares
- Krishnan Krish S — 2025-03-13 · S · 1,639 shares
- Krishnan Krish S — 2025-03-13 · S · 4,579 shares
- Krishnan Krish S — 2025-03-13 · S · 10,937 shares
- Krishnan Krish S — 2025-03-13 · S · 6,514 shares
- Krishnan Krish S — 2025-03-13 · S · 1,331 shares
- Krishnan Suma — 2025-03-13 · S · 1,639 shares
Adoption dates in Krystal Biotech, Inc. 6
- 2024-06-13 — stated in 2 filings
- 2024-09-12 — stated in 2 filings
- 2025-09-04 — stated in 8 filings
- 2025-11-06 — stated in 1 filing
- 2025-11-25 — stated in 2 filings
- 2026-02-23 — stated in 2 filings
Results prints in Krystal Biotech, Inc. 6
- 2025-05-06
- 2025-08-04
- 2025-11-03
- 2026-01-12
- 2026-02-17
- 2026-08-03
Trades before a print in Krystal Biotech, Inc. 0
- 8 days before the 2026-02-17 print — 2026-02-09 · S · ROMANO KATHRYN · 2,000 shares
- 8 days before the 2026-02-17 print — 2026-02-09 · S · ROMANO KATHRYN · 5,700 shares
- 8 days before the 2026-02-17 print — 2026-02-09 · S · ROMANO KATHRYN · 2,824 shares
- 8 days before the 2026-02-17 print — 2026-02-09 · S · ROMANO KATHRYN · 928 shares
- 8 days before the 2026-02-17 print — 2026-02-09 · S · ROMANO KATHRYN · 552 shares
- 8 days before the 2026-02-17 print — 2026-02-09 · S · ROMANO KATHRYN · 400 shares
- 8 days before the 2026-02-17 print — 2026-02-09 · S · ROMANO KATHRYN · 96 shares
- 19 days before the 2025-08-04 print — 2025-07-16 · S · Krishnan Krish S · 1,389 shares
- 19 days before the 2025-08-04 print — 2025-07-16 · S · Krishnan Krish S · 1,529 shares
- 19 days before the 2025-08-04 print — 2025-07-16 · S · Krishnan Suma · 1,529 shares
- 19 days before the 2025-08-04 print — 2025-07-16 · S · Krishnan Suma · 1,389 shares
- 20 days before the 2025-08-04 print — 2025-07-15 · S · Krishnan Krish S · 2,184 shares
Interval to Krystal Biotech, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 7within 10 days
- 8shortest, days
- 26no later print
- ROMANO KATHRYN 2026-02-09 · S · 8 days before the 2026-02-17 print · Chief Accounting Officer
- ROMANO KATHRYN 2026-02-09 · S · 8 days before the 2026-02-17 print · Chief Accounting Officer
- ROMANO KATHRYN 2026-02-09 · S · 8 days before the 2026-02-17 print · Chief Accounting Officer
- ROMANO KATHRYN 2026-02-09 · S · 8 days before the 2026-02-17 print · Chief Accounting Officer
- ROMANO KATHRYN 2026-02-09 · S · 8 days before the 2026-02-17 print · Chief Accounting Officer
- ROMANO KATHRYN 2026-02-09 · S · 8 days before the 2026-02-17 print · Chief Accounting Officer
- ROMANO KATHRYN 2026-02-09 · S · 8 days before the 2026-02-17 print · Chief Accounting Officer
Adoption dates Krystal Biotech, Inc. states
- 2024-06-13 in 2 filings
- 2024-09-12 in 2 filings
- 2025-09-04 in 8 filings
- 2025-11-06 in 1 filing
- 2025-11-25 in 2 filings
- 2026-02-23 in 2 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on June 13, 2024”
Reported results dates on file
- 2025-05-06
- 2025-08-04
- 2025-11-03
- 2026-01-12
- 2026-02-17
- 2026-08-03
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.